BRISE PHARMA
Brise Pharma operates in the scientific research and technical service industry.
BRISE PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
150 M CNY
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Aokai Zhihui Keji
Aokai Zhihui Keji is a scientific research and technical service industry.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Xinyu Hongtu
Xinyu Hongtu is a scientific research and technical service company.
Investors List
Sinopharm Capital
Sinopharm Capital investment in Angel Round - Brise Pharma
BioTrack Capital
BioTrack Capital investment in Angel Round - Brise Pharma
Qiming Venture Partners
Qiming Venture Partners investment in Angel Round - Brise Pharma
More informations about "Brise Pharma"
Brise Pharmaceuticals
Established in June 2021 in Shanghai, China. Brise Pharma stands as a clinical stage biopharmaceutical company with a major focus on the development of innovative and highly …See details»
Brise Pharma - Crunchbase Company Profile & Funding
Organization. Brise Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Brise …See details»
Brise Pharma - Funding, Financials, Valuation & Investors
Brise Pharma is funded by 9 investors. Vinner Therapeutics and China Gas Yijing are the most recent investors. Which investors participated in the most funding rounds?See details»
Brise Pharma 2025 Company Profile: Valuation, …
Brise Pharma General Information Description. Developer of new biopharmaceutical drugs designed for treating pain. The company focuses on …See details»
Brise Pharmaceuticals
Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for chronic pain, announced that the company’s pipeline BR007 has been granted Orphan Drug …See details»
Brise Pharma - Company Profile - Tracxn
Apr 23, 2024 Brise Pharma - Developer of therapeutics for severe pain conditions. Raised a total funding of $13.8M over 1 round from 5 investors. Brise Pharma has 246 competitors.See details»
Brise Pharmaceuticals - VentureRadar
" Brise Pharmaceuticals is a clinical stage biopharmaceutical company that specializes in developing innovative treatments for severe pain conditions, such as migraine, inflammatory …See details»
Brise Pharmaceuticals
At Brise pharma, collaboration is one of our core values. We strive to establish mutually beneficial, long-term external partnerships to accelerate innovation and maximize pipeline value by fully …See details»
Company profile for Brise Pharma - PharmaCompass
Founded in June 2021 in Shanghai, China, Brise Pharma is a clinical-stage biopharmaceutical firm specializing in the creation of innovative and distinct therapeutic options for seSee details»
Brise Pharma - Crunchbase
Companies like Brise Pharma include OncoHost, ARA, and Cyteir Therapeutics. Faron Pharmaceuticals Turku , Western Finland , Finland 13 Contacts 11-50 employeesSee details»
Brise Pharma - Products, Competitors, Financials, Employees ...
Mar 21, 2022 Brise Pharma is committed to the research and development of biopharmaceuticals. The main research and development location is in Shanghai, and the …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
Apr 22, 2024 Brise has advanced two molecules to the clinical stage in US and China. The funds raised will be used to advance the company's product pipeline in the preclinical and clinical …See details»
Brise Pharmaceutical $20 Mn in Pre-Serie A and Pre-Series A+
Apr 23, 2024 Brise Pharmaceuticals, which specializes in cutting-edge pain management strategies for both acute and chronic conditions, has secured nearly USD 20 million in pre …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and
Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing with a total of …See details»
Brise Pharma - Raised $13.8M Funding from 5 investors - Tracxn
Feb 25, 2025 Brise Pharma has raised a total funding of $13.8M over 1 round from 5 investors. Investors include Qiming Venture Partners, BioTrack Capital and 3 others. Their latest funding …See details»
Brise Pharmaceuticals
Recently, Brise Pharmaceuticals Co. Ltd. (Brise), a clinical-stage, pioneering company specializing in innovative treatments for acute and chronic pain, announced that Dr. Danny …See details»
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre …
Apr 23, 2024 The organization's vision is to provide safe, effective, and accessible pain relief solutions for the multitude of patients worldwide grappling with poorly managed pain con …See details»
Brise Pharma Closes $20 Million in A Rounds for Novel Pain Drugs
Shanghai Brise Pharma completed Pre-A and Pre-A+ financings worth almost $20 million to advance clinical trials of two candidates for pain in the US and China. The company develops …See details»
Brise Pharma - Updates, News, Events, Signals & Triggers
Brise Pharma operates in the scientific research and technical service industry. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 In response, pharma leaders have begun exploring fundamental changes to their capabilities, talent, and processes. ... Thirty-seven of them expect their organization to pursue …See details»